Select a Region
North America

Your hub for company news and information

EVERSANA
Posted on 11月 27, 202311/27/23

EVERSANA Builds on Commitment to “Pharmatize” AI with Amazon Web Services, Introduces Transformative Medical & Regulatory Review Solution

Read More
EVERSANA
Posted on 11月 20, 202311/20/23

EVERSANA to Use Adobe Firefly for Enterprise in Creative Development & Modular Content Production for Life Sciences Marketing

EVERSANA
Posted on 11月 6, 202311/6/23

EVERSANA INTOUCH Named Global Independent Pharma Agency of the Year by London International Awards

EVERSANA
Posted on 10月 31, 202310/31/23

Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healthcare Costs for Patients Using GIMOTI Over Oral Metoclopramide Presented at the American College of Gastroenterology 2023

EVERSANA
Posted on 10月 26, 202310/26/23

EVERSANA Earns Great Place to Work Recognition for Fifth Consecutive Year, Now Certified Across Seven Countries

EVERSANA
Posted on 10月 11, 202310/11/23

EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition

EVERSANA
Posted on 9月 19, 20239/19/23

Sy Pretorius, EVERSANA Chief Operating Officer, Named to Prestigious PharmaVoice 100 List for 2023

EVERSANA
Posted on 9月 18, 20239/18/23

EVERSANA Unveils ACTICS eAccess, New Technology-Enabled eBV and ePA Patient Support Platform to Improve Patient Access and Accelerate Speed to Therapy

EVERSANA
Posted on 9月 6, 20239/6/23

EVERSANA Names Ryan Sparks Chief Information Officer  

EVERSANA
Posted on 8月 30, 20238/30/23

EVERSANA Unveils EVERSANA ORCHESTRATE, Life Science Industry’s First End-to-End Omnichannel Solution Driving Brand Connectivity and Activating Commercialization Services

EVERSANA
Posted on 7月 25, 20237/25/23

Evoke Pharma and EVERSANA Announce Abstract Selection for Plenary Oral Presentation at The American College of Gastroenterology (ACG) 2023 Annual Meeting